SYK
$358.98
Stryker
($.73)
(.20%)
SYK
Earnings Whisper ®
N/A
3rd Quarter September 2024
Consensus:  $2.78
Revenue:  $5.37 Bil
Tuesday
Oct 29
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SYK reports earnings?
Beat
Meet
Miss

Where is SYK's stock price going from here?
Up
Flat
Down
Stock chart of SYK
Analysts
Summary of analysts' recommendations for SYK
Score
Grade
Pivots
Resistance
$371.57
$368.29
$363.64

$360.36

Support
$355.71
$352.43
$347.78
Tweet
Growth
Description
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Peers
Boston ScientificAbbottBecton, DickinsonWaters3MResMedTeleflexBaxter InternationalIntegra LifeSciences HoldingsMerit Medical Systems